Servier will be responsible for development and global commercialisation of the therapy for several indications.

A lucky Virginia lottery player scored a top prize win from a scratch-off game he bought after getting new tires, lottery ...

Servier announces a strategic worldwide licensing agreement for Black Diamond Therapeutics' BDTX-4933 for solid tumors for an ...

Servier and Black Diamond Therapeutics (BDTX) announced a strategic worldwide licensing agreement for BDTX-4933, a potential best-in-class ...

Black Diamond Therapeutics has found a partner for its deprioritized solid tumor candidate. Five months after cutting support ...

The partnership underscores Servier’s commitment to developing targeted therapies that address unmet medical needs in oncology Servier will ...

Black Diamond said Servier will develop and commercialize BDTX-4933, a small molecule designed by the Cambridge, Mass., company to address unmet medical needs in RAF/RAS-mutant solid tumors.

Black Diamond Therapeutics (NASDAQ:BDTX – Get Free Report) had its price objective upped by equities researchers at HC Wainwright from $11.00 to $12.00 in a note issued to investors on ...

Black Diamond Equipment BD Vision harnesses are being recalled due to premature degradation of its construction and materials ...

The outpouring of tributes to Angie Stone, one of the leading lights of neo-soul has lit the spark for many fans to dig out ...

The black diamonds that are found on tape measures have been a source of confusion for many - but it turns out that they ...

Black Diamond Therapeutics presents a compelling investment opportunity with strong potential, balanced by inherent biotech ...